AHFS January 2022 Update

This update contains 2 new monographs and 43 revised monographs.

New monographs:  Asciminib; Tick-borne Encephalitis Vaccine

Revised monographs:  Linezolid; Fondaparinux; Flurbiprofen; Bedaquiline; Olaparib; Obeticholic Acid; Rucaparib; Niraparib; Pretomanid; Lefamulin; Tazemetostat; Cefiderocol; Capmatinib; Ofatumumab; COVID-19 Vaccine (Pfizer-BioNTech); Relugolix; Fenoprofen; Indomethacin; Mefenamic Acid; Tolmetin; Sulindac; Prochlorperazine; Trifluoperazine; Perphenazine; fluPHENAZine; Neostigmine; Molindone; Meclofenamate; Loxapine; Chloroquine; Hydroxychloroquine; Thiothixene; Aspirin; Salsalate; Phenothiazines General Statement; Diflunisal; Piroxicam; Ketoprofen; Pimozide; cloZAPine; Etodolac; Nabumetone; Oxaprozin